menu
    • menu

    Company profile for Maxion Therapeutics

    Pfanstiehl, a global leader in the manufacture of cGMP high purity, low endotoxin, low metals (HPLE-LM)TM injectable grade excipients.

    Virtual Booth

    Contact Supplier

    Global Pharma Healthcare: Setting the global benchmark in quality, innovation, and care

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    Phyton is a World Leader in Plant Cell Fermentation Technology and Commercial Manufacturing.

    Virtual Booth

    Contact Supplier

    Farmak works in the development, production and marketing of APIs, Intermediates & Specialties// FDA inspected.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Developer of drug discovery platform designed to generate antibody-like therapeutics to solve ion channel and GPCR-driven diseases. The company combines ion channel-modulating mini-proteins found in venom and other sources called knottins into the antibody surface to create mixtures by preserving the ion channel modulating the function of knottins while enjoying the optimum drug-like properties of antibodies. enabling patients...
    Developer of drug discovery platform designed to generate antibody-like therapeutics to solve ion channel and GPCR-driven diseases. The company combines ion channel-modulating mini-proteins found in venom and other sources called knottins into the antibody surface to create mixtures by preserving the ion channel modulating the function of knottins while enjoying the optimum drug-like properties of antibodies. enabling patients to treat diseases such as chronic pain, autoimmune disorders, and heart disease.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Maxion Therapeuticsunitedkingdom_new Flag
    Country
    Country
    United Kingdom
    Address
    Address
    Babraham Research Campus Cambridge CB22 3AT
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.maxiontherapeutics.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/maxion-tx/?originalSubdomain=uk
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Maxion Therapeutics Names Joel Edwards Chief Business Officer
    Maxion Therapeutics Names Joel Edwards Chief Business Officer

    01 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/01/3159504/0/en/Maxion-Therapeutics-Appoints-Joel-Edwards-as-Chief-Business-Officer.html

    GLOBENEWSWIRE
    01 Oct 2025
    Share Share
    Maxion Therapeutics Appoints Dr. Santiago Arroyo to Board
    Maxion Therapeutics Appoints Dr. Santiago Arroyo to Board

    27 Aug 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/08/27/3139928/0/en/Maxion-Therapeutics-Strengthens-Board-with-Appointment-of-Dr-Santiago-Arroyo-as-a-Non-Executive-Director.html

    GLOBENEWSWIRE
    27 Aug 2025
    Share Share
    Maxion Appoints Dr. Stefan As Chief Development Officer
    Maxion Appoints Dr. Stefan As Chief Development Officer

    17 Jun 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/06/17/3100584/0/en/Maxion-Therapeutics-Appoints-Dr-Stefan-H%C3%A4rtle-as-Chief-Development-Officer.html

    GLOBENEWSWIRE
    17 Jun 2025
    Share Share
    Maxion Therapeutics Raises $72M in Series A Financing
    Maxion Therapeutics Raises $72M in Series A Financing

    17 Mar 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/03/17/3043657/0/en/Maxion-Therapeutics-Raises-72-million-58-million-in-an-Oversubscribed-Series-A-Financing-to-Advance-its-KnotBody-Pipeline-and-Platform.html

    GLOBENEWSWIRE
    17 Mar 2025
    Share Share
    Maxion Therapeutics Welcomes Dr Arndt Schottelius as New CEO
    Maxion Therapeutics Welcomes Dr Arndt Schottelius as New CEO

    01 Feb 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/maxion-therapeutics-welcomes-dr-arndt-schottelius-as-new-ceo-302049474.html

    PR NEWSWIRE
    01 Feb 2024
    Share Share
    Maxion Therapeutics Appoints Eva-Lotta Allan as Chair of its Board of Directors
    Maxion Therapeutics Appoints Eva-Lotta Allan as Chair of its Board of Directors

    21 Sep 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/ion-channel-drug-developer-maxion-therapeutics-appoints-eva-lotta-allan-as-chair-of-its-board-of-directors-301933959.html

    PR NEWSWIRE
    21 Sep 2023
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search